National Comprehensive Cancer Network. (2021). Rectal Cancer. Version 1. 2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf (Accessed: April 1 2021).

Abdalmassih M. Sivananthan G. Raizman Z. et al.

Prognostic markers ofrecurrence and survival in rectal cancer treated with neoadjuvant che-moradiotherapy and surgery.

Colorectal Cancer. 2018; 7: CRC02Fleming F.L. Pahlman L. Monson J.R.

Neoadjuvant therapy in rectal cancer.

Dis Colon Rectum. 2011; 54: 901-912Rödel C. Martus P. Papadoupolos T. et al.

Prognostic Significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

J. Clin. Oncol. 2005; 23: 8688-8696Burbach J.M. Verkooijen H.M. Intven M. et al.

RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): Study protocol for a randomized controlled trial.

Trials. 2015; 22: 58https://doi.org/10.1186/s13063-015-0586-4Garcia-Aguila J. Patil S. Kim J.K. et al.

Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.

J. Clin. Oncol. 2020; 38: 4008Jakobsen A. Ploen J. Vuong T. et al.

Dose effect relationship in chemoradiotherapy for locally advanced rectal cancer: A randomized trial comparing two radiation doses.

Int J Radiat Oncol Biol Phys. 2012; 86: 949-954Burbach J.P. den Harder A.M. Intven M. et al.

Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis.

Radiother Oncol. 2014; 113: 1-9Nijkamp J. de Jong R. Sonke J.J. et al.

Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients.

Radiother Oncol. 2009; 92: 202-209Myerson R.J. Garofalo M.C. Naga I.E. et al.

Elective clinical target volume for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas.

Int J Radit Oncol Biol Phys. 2009; 74: 824-830

ICRU, Report 62. (1999). Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), ICRU Report 62. Bethesda, Maryland: International Commission on Radiation Units and Measurements.

Chong I. Hawkins M. Hansen V. et al.

Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computer tomography.

Int J Radiat Oncol Biol Phys. 2011; 81: e431-e438Daly M.E. Murphy J.D. Mok E. et al.

Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy?.

Pract Radiat Oncol. 2011; 1: 85-94Nijkamp J. Swellengrebel M. Hollmann B. et al.

Repeat CT assessed CTV variation and PTV margins or short- and long-course pre-operative RT of rectal cancer.

Radiother Oncol. 2012; 102: 399-405Brierley J.D. Dawson L.A. Sampson E. et al.

Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum.

Int J Radiatino Oncology Biol Phys. 2011; 80: 97-102Nuyttens J.J. Robertson J. Yan D. et al.

The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment.

Radiat Oncol Biol Phys. 2002; 53: 497-503Allal A. Bischoff S. Nouet P.

Impact of the ‘‘belly board” device on treatment reproducibility in preoperative radiotherapy.

Strahlenther Onkol. 2001; 178: 259-262Nijkamp J. de Jong R. Sonke J.-J. et al.

Target volume shape variation during irradiation of rectal cancer patients in supine position: Comparison with prone position.

Radiother Oncol. 2009; 93: 285-292de Jong R. Lutkenhaus L. van Wieringen N. et al.

Plan selection strategy for rectum cancer patients: An interobserver study to assess clinical feasability.

Radiother Oncol. 2016; 120: 207-211Rosa C. Caravatta L. Tommaso M.D. et al.

Cone beam computer tomography for organ motion evaluation in locally advanced rectal cancer patients.

La radiologia medica. 2020; 126: 147-154Alickikus Z.A. Kuru A. Aydin B. et al.

The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy.

J. Radiat. Res. 2020; 61: 335-342

The anatomy of the rectum and anal canal.

Surgery (Oxford). 2011; 21: 5-10van Herk M. Remeijer P. Rasch C. et al.

The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy.

Int J Radiat Oncol Biol Phys. 2000; 47: 1121-1135Kachnic L.A. Winter K. Myerson R.J. et al.

RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycinC for the reduction of acute morbidity in carcinoma of th anal canal.

Int J Radiat Oncol Biol Phys. 2013; 1: 27-33Valentini V. Gambacorta M.A. Barbaro B. et al.

International consensus guidelines on Clinical Target Volume delineation in rectal cancer.

Radiother Oncol. 2016; 47: 195-201